``apologies...error in haste and i stand corrected. Substitute warrants outstanding for ``debentures`` , which represent apx possible 200m future shares of common if memory serves? ``

Fully diluted after conversion of all warrants would be 423 million. Therefore it appears you may have to adjust your number by about 130 million. No great oversight.

``Why would any company who professes to maintain such a powerful revenue generating patent portfolio continue to write language into deals that allow any party to openly short into the common, and admittedly allow for the effect of the erosion of the value of same, to the obvious detriment of retail shareholders? PTSC has been pretty outspoken about rewarding the retail shareholders yet this language is in conflict imo.

Why would PTSC allow AMD (or any of the listed shareholders and/or their affiliates) in the most recent SB-2 to openly short the common stock to convert into if they didn`t have to``

The shorting was allowed in previous financing vehicles - IT IS NOTHING NEW. You either know better, and don`t care about another ``slight`` oversight, or you haven`t done as much research as you are pretending to have done.

Nothing wrong with trading, as you`ve admitted you are a trader. Posting misleading info is wrong though. But then you knew that, didn`t you.